Historical record - last NADAC effective date: 5/22/2024
Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.1822 per EA under NDC 69315016001. Its NADAC has been published 56 times since May 10, 2023.
FDA first approved this application on Mar 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315016001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/22/2024
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211619FDA Approved
3/9/2021
TE Code
AB
On Market Since
4/15/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 56 times since May 10, 2023, and over the history we have for it it has declined 34.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1822 per EA |
|---|---|
| All-time high | $0.3191 (Jul 12, 2023) |
| All-time low | $0.1819 (Apr 17, 2024) |
| Median price | $0.2657 |
| Average price | $0.2593 |
| Largest weekly change | -31.5% (Apr 17, 2024) |
| Weeks tracked | 56 |
| Tracking since | May 10, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-32.6%
5Y
N/A
All
-34.8%
Last surveyed May 29, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.1822 per EA (NDC 69315016001), effective May 29, 2024.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 34.8%. It has been tracked across 56 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since May 10, 2023, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1819 (Apr 17, 2024) to a high of $0.3191 (Jul 12, 2023), with a median of $0.2657 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN 50 MG CAPSULE, is $0.1535 per EA — about 16% below DOXEPIN 50 MG CAPSULE.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 69315016001) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.